FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Strep topics
Streptococcus
Daptomycin
Antibiotic
Immunogenic
Nucleic Acid
Streptomyces
Pathogenic
Probiotics
Lactobacillus
Chromatograph
Antibiotics
Therapeutical
Chromatography
Solubility
Amino Acid

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Strep patents



      
           
This page is updated frequently with new Strep-related patent applications. Subscribe to the Strep RSS feed to automatically get the update: related Strep RSS feeds. RSS updates for this page: Strep RSS RSS


Date/App# patent app List of recent Strep-related patents
08/21/14
20140235492
 Methods for preparing single domain antibody microarrays patent thumbnailMethods for preparing single domain antibody microarrays
The present invention relates to a method for preparing sd ab microarray comprising the step consisting of: —i) providing a host cell capable of expressing a biotinylation enzyme —ii) transforming said host cell with a nucleic acid encoding for a fusion protein wherein a single domain antibody is fused at its carboxy terminal end to a biotinylation peptide —iii) culturing said host cell in presence of biotin in such a way that said fusion protein and biotinylation enzyme are expressed, resulting in biotinylation of said fusion protein —iv) lysing said host cell as cultured at step iii) —v) spotting the lysate obtained at step iv) on a solid sup port coated with an agent selected from the group consisting of avidin, streptavidin and/or any art known derivative of these agents a further object of the invention relates to a sd ab microarray obtainable by the method of the invention.. .
08/21/14
20140234379
 Agent for inducing interferon production containing lactic acid bacteria patent thumbnailAgent for inducing interferon production containing lactic acid bacteria
This invention provides an ifn inducer comprising, as an active ingredient, lactic acid bacteria and capable of inducing ifn production, an immunopotentiating agent or prophylactic agent against virus infection comprising such inducer, and a food or drink product comprising such ifn inducer and having ifn-inducing activity, immunopotentiating activity, or prophylactic activity against virus infection. The agent for inducing ifn production comprises, as active ingredients, lactic acid bacteria that can activate plasmacytoid dendritic cells (pdcs) and promote ifn production, such as lactococcus garvieae nbrc100934, lactococcus lactis subsp.
08/21/14
20140234260
 Compositions and methods for probiotic recolonization therapies patent thumbnailCompositions and methods for probiotic recolonization therapies
The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic clostridia. The compositions further comprise one or more additional viable non-pathogenic or attenuated pathogenic microorganisms selected from the group consisting of bacteroides, eubacteria, fusobacteria, propionibacteria, lactobacilli, anaerobic cocci, ruminococcus, e.
08/14/14
20140228214
 Compositions comprising a streptomyces-based biological control agent and a fungicide patent thumbnailCompositions comprising a streptomyces-based biological control agent and a fungicide
The present invention relates to a composition comprising at least one biological control agent selected from the group consisting of streptomyces strains, preferably gougerotin-producing streptomyces strains such as streptomyces microflavus strain nrrl b-50550 and/or a mutant thereof having all the identifying characteristics of the respective strain, and/or at least one metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens and at least one fungicide (i) in a synergistically effective amount, with the proviso that the biological control agent and fungicide (i) are not identical. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts..
08/14/14
20140228213
 Compositions comprising a streptomyces-based biological control agent and an insecticide patent thumbnailCompositions comprising a streptomyces-based biological control agent and an insecticide
The present invention relates to a composition comprising at least one biological control agent selected from the group consisting of streptomyces microflavus strain nrrl b-50550 and/or a mutant thereof having all the identifying characteristics of the respective strain, and/or at least one metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens and at least one insecticide in a synergistically effective amount, with the proviso that the biological control agent and the insecticide are not identical. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts..
08/14/14
20140227313
 Group a streptococcal m-related proteins and methods of use patent thumbnailGroup a streptococcal m-related proteins and methods of use
Immunogenic group a streptococcus m-related polypeptides and peptides and immunogenic compositions comprising these m-related polypeptides and peptides are provided herein that evoke cross-opsonic and cross-protective anti-gas and anti-sdse antibodies in animals. Also provided are preparations comprising immunogenic compositions that comprise m-related polypeptides, peptides, or fusion proteins and that further comprise at least one additional group a streptococcus immunogen, such as an m peptide or spa peptide..
08/07/14
20140220589
 Ultrasensitive detection of beta hemolytic streptococcus patent thumbnailUltrasensitive detection of beta hemolytic streptococcus
The present invention is directed to a method for the ultrasensitive detection of beta hemolytic streptococcus, a bacterium implicated in strep throat, using a specific protease marker. Also disclosed is a device as well as a biosensor, both of which are useful for the detection of beta hemolytic streptococcus.
08/07/14
20140220066
 Group a streptococcus multivalent vaccine patent thumbnailGroup a streptococcus multivalent vaccine
Immunogenic compositions are provided herein that are useful for inducing an immune response specific against group a streptococcus (gas). Immunogenic compositions provided herein are multivalent and comprise a plurality of immunogenic peptides or fusion polypeptides comprising the immunogenic peptides that induce an immune response against gas.
08/07/14
20140220065
 Therapeutic application of s. pyogenes c-terminal peptide patent thumbnailTherapeutic application of s. pyogenes c-terminal peptide
A method for treating rheumatic heart disease comprising administering an immunogenic composition against group a beta hemolytic streptococcus. .
07/31/14
20140212450
 Protein-based streptococcus pneumoniae vaccines patent thumbnailProtein-based streptococcus pneumoniae vaccines
Vaccine compositions and methods for protecting a mammalian subject against infection with s. Pneumoniae are disclosed.
07/24/14
20140206040
Streptococcus dysgalactiae id9103 and method for production of hyaluronic acid using the same
Provided is a streptococcus dysgalactiae id9103 strain having accession number kctc11818bp, and a method of producing hyaluronic acid by culturing the strain to produce hyaluronic acid having an average molecular weight of 10,000,000 da or more.. .
07/24/14
20140205693
Bacterial extract for respiratory disorders and process for its preparation
The present invention relates to an extract from bacterial strains, such as staphylococcus, moraxella, klebsiella, streptococcus, and haemophilus. The extract is useful as a treatment for indications such as respiratory disorders, compositions comprising the extract, and processes of making the extract from media that do not pose a risk of prion diseases..
07/24/14
20140205634
Treatment of streptococcal infections
Methods of treating a streptococcus pneumoniae infection are described herein.. .
07/24/14
20140205623
Protein-based streptococcus pneumoniae vaccines
Vaccine compositions and methods for protecting a mammalian subject against infection with s. Pneumoniae are disclosed.
07/17/14
20140199347
Adjuvant compositions with 4-1bbl
Streptavidin(sa)-4-1bbl and tlr agonists such as monophosphoryl lipid a (mpl) exhibit surprising synergy as adjuvants, inducing immune responses against weak antigens. Accordingly, there are provided adjuvant compositions comprising 4-1bbl and a toll-like receptor (tlr) agonist, such as mpl, methods of inducing an immune response against an antigen in a subject, comprising administering to the subject (a) the antigen, (b) a tlr agonist and, (c) 4-1bbl, and methods of treating a tumor or a cancer in a subject, comprising administering to the subject (a) an antigen associated with the tumor or cancer, (b) a tlr agonist, and (c) 4-1bbl..
07/10/14
20140193461
Streptococcus vaccine compositions and methods of using the same
The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides immunogenic nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., innate and/or adaptive immune responses (e.g., for generation of host immunity against a bacterial species of the genus streptococcus (e.g., streptococcus pneumoniae))).
07/10/14
20140193429
Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof
The present invention relates to an isolated antigen from streptomyces coelicolor that is useful for developing, inter alia, vaccines against pathogenic bacteria of humans and animals. The present invention also relates to vaccines and antibodies developed using the isolated antigen.
07/10/14
20140193367
Method for reducing uremic toxins by probiotic composition and the manufacturing method thereof
The invention relates to a probiotic composition for reducing uremic toxins and the manufacturing method thereof. The probiotic composition comprises at least one selected from the group consisting of: lactobacillus plantarum bcrc 12251, lactobacillus paracasei bcrc 12188, streptococcus thermophilus bcrc 13869 and pharmaceutically acceptable vehicles, excipients, diluents, adjuvants, etc.
07/03/14
20140186865
Method for assaying plasminogen in a liquid medium, associated compositions and kit
The invention also relates to a liquid composition, a plasminogen assay kit for implementing this method and the use of a streptokinase activator selected from the group comprising a fibrin dd fragment and/or at least one dd fragment derivative.. .
07/03/14
20140186390
Conjugation process of bacterial polysaccharides to carrier proteins
Process for conjugation of bacterial saccharides including streptococcus pneumoniae and haemophilus influenzae saccharides by reductive amination are provided herein.. .
07/03/14
20140186389
Conjugation process of bacterial polysaccharides to carrier proteins
Process for conjugation of bacterial saccharides including streptococcus pneumoniae and haemophilus influenzae saccharides by reductive amination are provided herein.. .
07/03/14
20140186386
Methods for preventing and treating staphylococcus aureus colonization, infection, and disease
The invention provided herein relates to a method of preventing a staphylococcus aureus colonization and/or infection by administering a streptococcus pneumoniae strain, antigen thereof, or homologous staphylococcal antigen. The invention further relates to a method of treating a disease associated with a staphylococcus aureus colonization and/or infection by administering a streptococcus pneumoniae strain, antigen thereof, or homologous staphylococcal antigen..
06/26/14
20140179594
Streptococcus bacteriophage lysins for treatment of gram positive bacteria in companion animals and livestock
The present invention provides methods for the prophylactic and therapeutic amelioration and treatment of gram-positive bacteria in companion animals and livestock, including streptococcus and staphylococcus bacterial strains, including pathogenic and antibiotic-resistant bacteria, and related conditions. The methods of the invention utilize plyss2 and/or plyss1 lytic enzymes and variants thereof, including truncations thereof.
06/26/14
20140178399
Role of adam10 and its relevance to disease and therapeutics
Certain embodiments are directed to compositions and methods of inhibiting pathogenic bacterial infection involving adamio comprising administering an effective amount of a metalloprotease inhibitor to a patient. Certain embodiments are directed to method of inhibiting staphylococcal infection comprising administering an effective amount of a metalloprotease inhibitor to a patient.
06/19/14
20140171911
Apparatus and methods for clot dissolution
Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent.
06/19/14
20140171627
Multimeric biotinidase resistant multimodality probes
The present invention describes multimeric multimodality probes. In particular, the present invention discloses (strept)avidin specific multimeric biotinidase resistant multimodality probes..
06/12/14
20140161845
Anti-biofilm compounds
The present invention provides non-peptide compounds of formula (i) wherein: x is —(c1-c8)allcyl-, aryl or -aryl(c1-c8)alkyl-; y is —(c1-c8)alkyl- or absent; w is heteroaryl, (c3-c7)carbocycle or aryl, wherein any heteroaryl, (c3-c7)carbocycle or, aryl of w is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) z1 groups; r1 is (c1-c8)alkyl, (c2-c8)alkenyl, (c2-c8)alkynyl or aryl, wherein aryl is optionally substituted with one or more (e.g.
06/12/14
20140161781
Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same
The invention relates to a zinc-enriched biomass comprising living or subsequently killed micro-organisms, selected from the group consisting of streptococcus thermophilus and bifidobacterium animalis subsp. Lactis and combinations thereof, a method for the manufacture of said zinc-enriched biomass, as well as food preparations, nutraceutic products, functional foods, cosmetic and cosmeceutic products, and food supplements, comprising the said biomass.
06/12/14
20140161780
Compositions and methods for augmenting kidney function
A protein-rich nutritional food product composed of a probiotic and an edible isolated protein. The probiotic component may comprise lactobacillus, bacillus, streptococcus bifidobacteria, saccharomyces or leuconostoc.
05/29/14
20140147550
Utilization of an enzymatic complex in farm animals feed
The invention relates to a method of supplementing farm animal feed with an enzymatic complex including a mixture of proteases, obtained by culturing a streptomyces fradiae strain, wherein among this mixture of proteases one of them has an isoelectric point of around 7.0 and another has an isoelectric point of around 8.0. The invention also relates to feed compositions for farm animals including the enzymatic complex as well as the manufacturing process enzymatic complex thereof..
05/22/14
20140142284
Manufacturing and purification processes of complex protein found in fraction iv to make a separated apo, transferrin, and alpha 1 anti strepsin (a1at) or a combined transferrin/apo/human albumin/a1at and all new found proteins
Manufacturing and purification processes of complex protein found in fraction iv to make a separated apo, transferrin, and alpha 1 antitrypsin (a1at) or a combined transferrin/apo/human albumin/a1at and all new found proteins. A complex of all proteins found currently in plasma, cryoprecipitate, fraction iii and many newly found proteins now being identified or any substances which are known proteins or unknown proteins which contain good healthy cells and the combination of any of these known or unknown proteins which contain any one of these good healthy cells: neutrophil, lymphocyte, eosinophil, basophil, and macrophage, and their potential applications for treating a wide variety of diseases and other physical conditions and disorders, and for maintaining health..
05/22/14
20140142147
Carbocyanines for g-quadruplex dna stabilization and telomerase inhibition
Cyanines which selectively bind to g-quadruplex dna complexes, particularly quadruplexes expressed in cancer cells, and methods of making and using thereof are described herein. The cyanine can be a symmetrical or unsymmetrical streptocyanine, hemicyanine, closed chain cyanine, or combinations thereof.
05/22/14
20140142144
Oxazolidinone compounds and their uses in preparation of antibiotics
The invention belongs to the field of medicaments, and particularly relates to oxazolidinone compounds and their uses in the preparation of antibiotics. A technical problem to be solved by the invention is to provide new oxazolidinone compounds having the structure represented by formula i.
05/22/14
20140141446
Aptamers that are specific for immunoglobulin-binding cell wall proteins
The invention relates to an aptamer that binds to protein a, g or l, protein a-, g- or l-containing substances, and also to protein a-, g- or l-containing microorganisms, in particular staphylococcus aureus, streptococcus or peptostreptococcus, methods for detection and enrichment of protein a, g or l, protein a-, g- or l-containing substances or protein a-, g- or l-containing microorganisms in which the aptamer is used, and also a kit, a biosensor, a lateral flow assay device and a measuring instrument which contain such an aptamer and can be used in said methods.. .


Popular terms: [SEARCH]

Strep topics: Streptococcus, Daptomycin, Antibiotic, Immunogenic, Nucleic Acid, Streptomyces, Pathogenic, Probiotics, Lactobacillus, Chromatograph, Antibiotics, Therapeutical, Chromatography, Solubility, Amino Acid

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Strep for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Strep with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.3377

3265

72 - 0 - 71